Sen Amy Klobuchar (D, Minn) and Sen Chuck Grassley (R, Iowa) urged the Federal Trade Commission (FTC) to promptly release the agency’s 2013 and 2014 reports about “pay-for-delay” settlements. Under such agreements, brand-name drug companies pay generic drug manufacturers to delay marketing their lower-cost products.
“Pay-for-delay agreements deny consumer access to more affordable alternatives to brand medications,” Klobuchar and Grassley, lead sponsors of the Preserve Access to Affordable Generics Act, wrote in a letter dated October 29 to FTC Chairwoman Edith Ramirez.
Rubin R. Senators Request Data About “Pay-for-Delay”. JAMA. 2015;313(2):124. doi:10.1001/jama.2014.17746
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: